---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-26-000349"
form_type: "8-K"
ticker: "ADCT"
cik: "0001771910"
company_name: "ADC Therapeutics SA"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:54:55.924472+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ADC Therapeutics posts updated corporate presentation with no material new disclosures

## Summary
- ADC Therapeutics made available an updated corporate presentation dated January 2026 via 8-K filing.
- The presentation excerpt contains only forward-looking statements boilerplate; no specific financial data or events.
- No changes to guidance, pipeline status, or leadership were disclosed in the filing.

## SEC filing metadata
- accession: 0000950103-26-000349
- form_type: 8-K
- ticker: ADCT
- cik: 0001771910
- company_name: ADC Therapeutics SA
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771910/000095010326000349/0000950103-26-000349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771910/000095010326000349/dp239825_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-26-000349
- JSON: https://secwatch.observer/filing/0000950103-26-000349.json
- Plain text: https://secwatch.observer/filing/0000950103-26-000349.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.